Home » Conferences & Events » Health Care » Drug Discovery and Development

Drug Discovery and Development

Methodological Challenges Associated with Meta-Analyses in Health Care and Behavioral Health Research
May 17, 2013

Meta-analysis is used to inform a wide array of questions ranging from pharmaceutical safety...

Orphan Drugs: Making Rare Disease Rarer
February 12, 2013

From the 15th Annual BIO CEO & Investor Conference at the Waldorf Astoria Hotel in New...

Clinical Trials Modernization Initiative
September 19, 2012

In an effort to bring innovative new medicines to patients more efficiently, while protecting...

Bringing Innovation to Neglected Disease Research and Development: Joint Report by BIO and BIO Ventures for Global Health
June 18, 2012

BIO Ventures for Global Health (BVGH) and the Biotechnology Industry Organization (BIO) have...

More Articles →

Letters, Testimony & Comments

Recombinant DNA: BIO Comments on WHO Guidelines on the Quality, Safety, and Efficacy of Biological Medicinal Products Prepared by Recombinant DNA Technology
April 19 2013
  The Biotechnology Industry Organization (BIO) appreciates the opportunity to comment on the “WHO Guidelines on the Quality...
Immunogenicity: BIO Comments on Draft Guidance on Immunogenicity Assessment for Therapeutic Protein Products
April 12 2013
Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to...
eSource: BIO Comments on FDA Draft Guidance on Electronic Source Data in Clinical Investigations
March 26 2013
  Re: Docket No. FDA–2010-D-0643:  Draft Guidance for Industry on Electronic Source Data in Clinical Investigations;...
Enrichment Strategies: BIO Submits Comments on FDA Draft Guidance on Enrichment Strategies for Clinical Trials
March 18 2013
  Dear Sir/Madam:   The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the...
eCTD: BIO Submits Comments on Providing Regulatory Submissions in Electronic Format
March 4 2013
  The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA or Agency) for the opportunity to...
More Letters, Testimony & Comments →

Press Releases

IFPMA, BIO and WADA Advance Anti-Doping Collaboration with the Launch of 2 Fields 1 Goal Campaign
July 23 2012
Groups Issue Booklet to Help Biotechnology and Pharmaceutical Companies Identify Pipeline Medicines with Doping...
BIO Supports Permanent Reauthorization of Programs to Encourage Development of Lifesaving Medications for Children
March 28 2012
Washington, D.C. (March 28, 2012) – BIO President and CEO Jim Greenwood issued the following statement in...
BIO Statement on New Bill to Extend Therapeutic Discovery Project Tax Credit
May 25 2011
WASHINGTON, D.C. (Wednesday, May 25, 2011) - Biotechnology Industry Organization (BIO) President and CEO Jim...
Representative Upton Honored as BIO Legislator of the Year
May 4 2011
WASHINGTON, D.C. (Tuesday, May 04, 2011) - The Biotechnology Industry Organization (BIO) announced today its...
Senator Casey Honored as BIO Legislator of the Year
May 4 2011
Pennsylvania Bio President Christopher Molineaux and BIO President and CEO Jim Greenwood present Senator...
More Press Releases →